Literature DB >> 23643894

Identification and characterization of OmpL as a potential vaccine candidate for immune-protection against salmonellosis in mice.

Youjun Yang1, Cuixiang Wan, Hengyi Xu, Hua Wei.   

Abstract

Salmonella is gram-negative flagellated bacteria that can cause food and waterborne gastroenteritis and typhoid fever in humans. Despite the importance of Salmonella infections in human and animal health, the target antigens of Salmonella-specific immunity remain poorly defined, the effectiveness of the currently available vaccines is also limited. Outer membrane proteins (OMPs) of Salmonella have been considered possible candidates for conferring protection against salmonellosis. OMPs interface the cell with the environment, thus representing important potential vaccine candidate for pathogen infection. We showed that the outer membrane porin L (OmpL) is a transmembrane β barrel (TMBB) protein, which forms 12 transmembrane β-strands. OmpL of S. Typhimurium is highly immunogenic, OmpL could evoke humoral and cell-mediated immune responses, and confer 100% protection to immunized mice against challenge with very high doses of S. Typhimurium. Besides, very efficient clearance of bacteria from the reticuloendothelial systems of immunized mice was seen. The homology search further revealed that OmpL is widely distributed and conserved, homologous proteins were identified in S. Typhi and Paratyphi by RT-PCR and western blot. We also found that anti-rOmpL serum harber a high bactericidal activity for Salmonella serovars tested in this study. Therefore, OmpL provide a promising target for the development of a candidate vaccine against Salmonella infection.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643894     DOI: 10.1016/j.vaccine.2013.04.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells.

Authors:  Seung-Joo Lee; Joseph Benoun; Brian S Sheridan; Zachary Fogassy; Oanh Pham; Quynh-Mai Pham; Lynn Puddington; Stephen J McSorley
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

Review 2.  Vaccination against Salmonella Infection: the Mucosal Way.

Authors:  Rémi Gayet; Gilles Bioley; Nicolas Rochereau; Stéphane Paul; Blaise Corthésy
Journal:  Microbiol Mol Biol Rev       Date:  2017-06-14       Impact factor: 11.056

3.  Identification of antigenic proteins of the nosocomial pathogen Klebsiella pneumoniae.

Authors:  Sebastian Hoppe; Frank F Bier; Markus von Nickisch-Rosenegk
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

4.  LptD is a promising vaccine antigen and potential immunotherapeutic target for protection against Vibrio species infection.

Authors:  Zhenzhong Zha; Chuchu Li; Weiyan Li; Zhicang Ye; Jianyi Pan
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

5.  Vaccination with Salmonella Typhi recombinant outer membrane protein 28 induces humoral but non-protective immune response in rabbit.

Authors:  Anjani Saxena; Rajesh Kumar; Mumtesh Kumar Saxena
Journal:  Vet World       Date:  2017-08-19

6.  Salmonella Typhimurium Adhesin OmpV Activates Host Immunity To Confer Protection against Systemic and Gastrointestinal Infection in Mice.

Authors:  Deepinder Kaur; Shraddha Gandhi; Arunika Mukhopadhaya
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

7.  Immune efficacy of five novel recombinant Bordetella bronchiseptica proteins.

Authors:  Yan Liu; Hui Chen; Qiang Wei; Chenwen Xiao; Quanan Ji; Guolian Bao
Journal:  BMC Vet Res       Date:  2015-07-30       Impact factor: 2.741

8.  The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles.

Authors:  Catherine J Reynolds; Claire Jones; Christoph J Blohmke; Thomas C Darton; Amelie Goudet; Ruhena Sergeant; Bernard Maillere; Andrew J Pollard; Daniel M Altmann; Rosemary J Boyton
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.